There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Synovus (SNV – Research Report) and CME Group (CME – Research Report) with bullish sentiments.
Synovus (SNV)
Wells Fargo analyst Timur Braziler maintained a Buy rating on Synovus yesterday and set a price target of $48.00. The company’s shares closed last Wednesday at $44.03, close to its 52-week high of $47.83.
According to TipRanks.com, Braziler is a 4-star analyst with an average return of 7.8% and a 59.8% success rate. Braziler covers the Financial sector, focusing on stocks such as Bank of NT Butterfield & Son, First Interstate Bancsystem, and Pinnacle Financial Partners.
Synovus has an analyst consensus of Moderate Buy, with a price target consensus of $49.21, an 11.1% upside from current levels. In a report released yesterday, Barclays also maintained a Buy rating on the stock with a $47.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
CME Group (CME)
In a report released today, Christopher Allen from Citi maintained a Buy rating on CME Group, with a price target of $240.00. The company’s shares closed last Wednesday at $216.00.
According to TipRanks.com, Allen is a 5-star analyst with an average return of 20.6% and a 78.9% success rate. Allen covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Apollo Global Management, and Raymond James Financial.
The word on The Street in general, suggests a Hold analyst consensus rating for CME Group with a $211.60 average price target.
Read More on SNV: